证券代码：300721 证券简称:怡达股份 公告编号：2025-016 江苏怡达化学股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 江苏怡达化学股份有限公司（以下简称"公司"）2024 年年度权益分派方 案已获 2025 年 4 月 18 日召开的 2024 年年度股东大会审议通过，现将权益分派 事宜公告如下： 一、股东大会审议通过的利润分配方案 1、公司拟以截止 2024 年 12 月 31 日的总股本 164,846,739 股为基数，每 10 股派发现金股利 0.3 元人民币（含税），预计派发现金股利人民币 4,945,402.17 元，剩余未分配利润滚存至下一年度。本次不送红股，也不进行资本公积金转增 股本。 在实施权益分派的股权登记日前公司总股本发生变动的，公司拟按照"现金 分红比例不变"的原则，对利润分配总额进行调整。 2、自分配方案披露至实施期间公司股本总额无变化。 3、本次实施的分配方案按照"现金分红比例不变"的原则，对利润总额进 行分配。 4、本次实施的分配方案与股东大会审议通过的分配方案及其调 ...

Group 1 - The epoxy propylene sector experienced a decline of 3.41%, ranking among the top losers in the market, with notable declines in stocks such as Hongqiang Co., which hit the daily limit down, and others like Hongbaoli, Yida Co., and Bohai Chemical [1][2] - The sector saw a net outflow of 9.23 billion yuan in principal funds, with 18 stocks experiencing net outflows, and 6 stocks seeing outflows exceeding 30 million yuan. Hongbaoli led the outflow with 5.56 billion yuan, followed by Hangjin Technology, Wanhua Chemical, and Hongqiang Co. [2][3] - The top stocks with net inflows included Satellite Chemical, Zhongchumai, and Shida Shenghua, with inflows of 332.33 million yuan, 2.50 million yuan, and 1.99 million yuan respectively [2][3] Group 2 - The top losers in the epoxy propylene sector included Hongbaoli (-8.60%), Hangjin Technology (-3.77%), and Hongqiang Co. (-9.98%), with significant trading volumes and turnover rates [2][3] - The overall market sentiment reflected a bearish trend, with various sectors such as sodium-ion batteries and transgenic technology also experiencing declines, indicating a broader market pullback [2]

Group 1 - The epoxy propylene concept increased by 3.06%, ranking 6th among concept sectors, with 20 stocks rising, including Hongqiang Co. and Hongbaoli, which hit the daily limit [1] - Notable gainers in the sector included Yinuowei, Bohai Chemical, and Meibang Technology, with increases of 10.15%, 6.47%, and 6.11% respectively [1] - The sector experienced a net outflow of 127 million yuan from main funds, with 8 stocks seeing net inflows, led by Hongbaoli with a net inflow of 130 million yuan [2][3] Group 2 - The top stocks by net inflow ratio included Hongqiang Co., Kent Catalysts, and Yida Co., with net inflow ratios of 11.71%, 8.89%, and 6.60% respectively [3] - The trading volume for Hongbaoli was 12,981.97 million yuan, with a daily turnover rate of 43.21% [3] - Stocks with significant declines included Huitong Technology and Satellite Chemical, which fell by 1.37% and 0.43% respectively [1][4]

Group 1 - The core viewpoint of the article highlights the significant rise in the stock prices of companies related to photolithography machines and photoresists, indicating a bullish trend in this sector [1] - Kaimeteqi's stock reached the daily limit, while Feikai Materials saw an increase of over 10%, showcasing strong market performance [1] - Other companies such as Xinlai Materials, Jiuri New Materials, Qiangli New Materials, Gaomeng New Materials, and Yida Co. also experienced stock price increases of over 5%, reflecting a broader positive sentiment in the industry [1]

■■■10■■■■■■■■■■■■ ■■■■■■■■■■■■ 5102.41■■■■■■■■■■■ 37.3%■■■■■■■ 99.79■■■ ■■■■■■■■■■■■■ | ■■■■■ | 2025■■■■ | 2024■■■■ | ■■■■■■■(%) | 2023■■■■ | | --- | --- | --- | --- | --- | | ■■■■■■■■■ | -0.2196 | 0.0302 | -827.15 | -0.1554 | | ■■■■■■■■ | 7.18 | 7.45 | -3.62 | 7.48 | | ■■■■■(■) | 3.88 | 3.88 | 0 | 3.84 | | ■■■■■■■(■) | 1.89 | 2.20 | -14.09 | 2.28 | | ■■■■■■■(■) | - | - | - | - | | ■■■■(■■) | 3.32 | 4.01 | -17.21 | 3.72 | | ■■■(■■) | -0.36 | 0.05 | -820 | -0.25 | | ■■■■■■(%) | -2.96 | 0.40 | -840 | -2.02 | ...

Financial Performance - The company's revenue for Q1 2025 was ¥332,208,223.13, a decrease of 17.18% compared to ¥401,113,424.53 in the same period last year[5] - The net loss attributable to shareholders was ¥36,205,500.36, representing a decline of 835.16% from a profit of ¥4,924,877.86 in the previous year[5] - The net cash flow from operating activities was negative at ¥48,764,684.34, a significant drop of 548.62% from ¥10,869,982.27 in the prior year[5] - The company reported a net loss for the quarter, with total other income decreasing to CNY 1,767,222.85 from CNY 2,574,241.46[20] - The company reported a net loss of ¥42,979,986.46 for the current period, compared to a net profit of ¥878,490.21 in the previous period[21] - Operating profit decreased significantly to -¥56,246,979.46 from ¥1,882,056.20 year-over-year[21] - Total revenue from operating activities was ¥350,639,263.32, down from ¥420,463,391.53 in the previous period, representing a decline of approximately 16.6%[23] - The total comprehensive income attributable to the parent company was -¥36,205,500.36, compared to ¥4,924,877.86 in the previous period[22] Asset and Liability Management - The company's total assets decreased by 4.03% to ¥2,528,104,944.43 from ¥2,634,363,081.76 at the end of the previous year[5] - Total liabilities decreased to CNY 1,333,054,898.04 from CNY 1,398,546,275.46, a reduction of 4.7%[19] - The company's equity attributable to shareholders decreased to CNY 1,183,935,361.37 from CNY 1,217,953,134.51, a decline of 2.8%[19] Cash Flow Analysis - The net cash flow from financing activities increased dramatically by 10,506.66% to ¥21,556,761.44, primarily due to an increase in bank borrowings[9] - Cash inflow from financing activities was ¥294,612,300.00, down from ¥341,062,238.20 in the previous period[24] - The company experienced a net cash outflow from investing activities of -¥30,456,275.52, compared to -¥31,276,537.48 in the previous period[24] - Cash and cash equivalents at the end of the period stood at ¥130,466,647.37, a decrease from ¥132,323,711.39 at the end of the previous period[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 19,787[12] - Liu Zhun holds 20.80% of shares, totaling 34,295,684 shares, with 25,721,763 shares under lock-up[12] - Shen Guixiu holds 12.28% of shares, totaling 20,235,980 shares, with no shares under lock-up[12] - Liu Zhaoxuan holds 6.01% of shares, totaling 9,908,500 shares, with no shares under lock-up[12] - The top 10 shareholders collectively hold significant stakes, with Liu Zhun, Shen Guixiu, and Liu Zhaoxuan being the largest[12] - The company has a total of 25,721,763 shares under lock-up for Liu Zhun, which are subject to transfer restrictions[14] - The company has established a consensus action agreement among major shareholders, including Liu Zhun and Shen Guixiu, effective from November 16, 2024[12] - The company has a total of 1,204,600 shares under lock-up for Cai Guoqing, with a release date set for December 18, 2024[14] - The company has not reported any changes in the number of shares lent or returned through margin trading among the top shareholders[12] - The company’s management has a significant number of shares under lock-up, ensuring stability in shareholding structure[14] Operational Efficiency - Management expenses were reduced by 62.07% to ¥12,761,684.15 from ¥33,647,274.32 year-on-year[8] - The company experienced a 3088.59% decline in operating profit, resulting in a loss of ¥56,246,979.46 compared to a profit of ¥1,882,056.20 in the previous year[8] - Total operating costs amounted to CNY 383,502,041.89, down 4.5% from CNY 402,424,549.94 in the prior period[20] - Research and development expenses for the quarter were CNY 4,526,443.13, slightly up from CNY 4,186,789.31 in the previous period[20] Impairment Losses - The company reported a significant increase in asset impairment losses, which rose by 767.72% to ¥6,500,483.35 compared to the previous year[8] - The company incurred a credit impairment loss of ¥234,727.22, while asset impairment losses totaled ¥6,500,483.35[21] Return on Investment - The weighted average return on net assets was -2.96%, down from 0.40% in the same period last year[5] - The company recorded a basic and diluted earnings per share of -¥0.2196, compared to ¥0.0302 in the previous period[22]

证券代码：300721 证券简称: 怡达股份 公告编号：2025-014 江苏怡达化学股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决议案的情形。 2、本次股东大会无涉及变更以往股东大会已通过决议的情形。 一、会议召开和出席情况 1、会议召开情况 江苏怡达化学股份有限公司（以下简称"怡达股份"或"本公司"）于 2025 年 3 月 28 日在巨潮资讯网（http://www.cninfo.com.cn）披露了《关于召开 2024 年年度股东大会的通知》。 （1） 会议召开时间： （1）出席的总体情况 出席本次大会现场会议的股东及股东授权代表和参加网络投票的股东共 147 人，代表公司有表决权的股份数为 73,379,016 股，占公司有表决权股份总数 的 44.5135%。 现场会议召开日期和时间：2025 年 4 月 18 日（星期五）下午 14:00 网络投票日期和时间：2025 年 4 月 18 日。其中，通过深圳证券交易所交易 系统进行网络投票的时间为 2025 年 4 ...

北京植德律师事务所 关于江苏怡达化学股份有限公司 2024 年年度股东大会的 法律意见书 植德京(会)字[2025]0029 号 北京市东城区东直门南大街 1 号来福士中心办公楼 12 层 邮编：100007 12th Floor, Raffles City Beijing Office Tower, No.1 Dongzhimen South Street, Dongcheng District, Beijing 100007 P.R.C 电话(Tel)：010-56500900 传真(Fax)：010-56500999 www.meritsandtree.com 北京植德律师事务所 关于江苏怡达化学股份有限公司 二〇二五年四月 2024年年度股东大会的 法律意见书 植德京(会)字[2025]0029号 致：江苏怡达化学股份有限公司 北京植德律师事务所（以下简称"本所"）接受江苏怡达化学股份有限公司 （以下简称"公司"或"怡达股份"）的委托，指派律师出席并见证公司2024 年年度股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以 ...

江苏怡达化学股份有限公司 2024 年度内部控制审计报告 天衡专字(2025) 00261 号 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部控制评价指 引》的规定,建立健全和有效实施内部控制,并评价其有效性是怡达股份董事会的责任。 二、注册会计师的责任 天衡会计师事务所（特殊普通合伙） 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查理 内部控制审计报告 天衡专字(2025) 00261 号 江苏怡达化学股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我们审计了江 苏怡达化学股份有限公司(以下简称"怡达股份")2024年12月 31 日财务报告内部控制的 有效性。 一、企业对内部控制的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表审计意见, 并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于情况的变化 可能导致内部控制变得不恰当,或对控制政策和程序遵循的程度降低,根据内 ...

证券代码：300721 证券简称: 怡达股份 江苏怡达化学股份有限公司 2024 年度内部控制自我评价报告 江苏怡达化学股份有限公司全体股东： 根据《企业内部控制规范》及其配套指引和其他内部控制监管要求（以下简 称"企业内部控制规范体系"），结合本公司（以下简称"公司"）内部控制制度 和评价办法，在内部控制日常监督和专项监督的基础上，董事会对公司 2024 年 12 月 31 日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一、重要声明 建立健全并有效实施内部控制是本公司董事会及管理层的责任。监事会对董 事会建立与实施内部控制进行监督，管理层负责组织、领导公司内部控制的日常 运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在 任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整 性承担个别及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合理合规、资产安全、财务报 告及相关信息真实完整，提高经营效率和效果，促进实现发展战略。由于内部控 制存在的固有局限性，故仅能为实现上述目标提供合理保证。此外，由于情况的 变化可能导致内部控制变得不恰当，或对控制政策和程 ...